Medical Action Industries to Participate in Roth Capital Partners 19TH Annual Growth Conference

HAUPPAUGE, N.Y.--(BUSINESS WIRE)--Feb. 1, 2007--Medical Action Industries Inc. (NASDAQ/MDCI), a leading supplier of medical and surgical disposable products, today announced that it has agreed to acquire an office building in the Hauppauge, New York area consisting of approximately 28,000 square feet.

Paul D. Meringolo, Chief Executive Officer and President of Medical Action Industries Inc. commented that "Our new office building, which is more than double the size of our current corporate headquarters, was necessary in order to meet the Company's enormous growth. In the last six years, Medical Action has grown almost four times in size. Our new Corporate headquarters will be able to accommodate up to an additional 100 employees to its current staff in New York," Mr. Meringolo added.

The building will be financed from cash on hand, bank indebtedness, together with cash provided from the Company's operations. The transaction is expected to close in March with an anticipated occupancy in the Fall/Winter of 2007.

It was further announced today that Medical Action will be presenting at the Roth Capital Partners 19th Annual Growth Stock Conference to be held on February 20-22, 2007 at the Ritz Carlton Laguna Niguel in Dana Point, California. The Medical Action presentation will be webcast on Tuesday, February 20, 2007 at 2:30 p.m. (PST). The presentation by Medical Action's CEO and President, Paul D. Meringolo, will be audio broadcast live and can be found by accessing the webcast link on the Medical Action Website at: www.medical-action.com.

Medical Action is a diversified manufacturer of disposable medical devices. Its products are marketed primarily to acute care facilities in domestic and certain international markets. Further, Medical Action has expanded its target market to include physician, dental and veterinary offices, out-patient surgery centers and long-term care facilities. Medical Action is a leading manufacturer and distributor of many of its products in the markets we compete in. Our products are marketed through an extensive network of direct sales personnel and independent distributors. Medical Action has preferred vendor agreements with national distributors, as well as contracts with nearly every major group purchasing alliance. The Company's common stock trades on the NASDAQ Global Select Market under the symbol MDCI and is included in the Russell 2000 Index.

This news release contains forward-looking statements that involve risks and uncertainties regarding Medical Action's operations and future results. Please see the Company's filings with the Securities and Exchange Commission, including, without limitation, the Company's Form 10-K and Form 10Q's, which identify specific factors that would cause actual results or events to differ materially from those described in the forward-looking statements.

CONTACT: Medical Action Industries Inc.
Richard G. Satin, 631-231-4600
Vice President of Operations and General Counsel

SOURCE: Medical Action Industries Inc.